Becton Dickinson's HPV assay was FDA-approved for use with clinician-collected samples in 2018 and received approval for sample self-collection in May.

The firm's HPV assay was FDA-approved for use with clinician-collected samples in 2018 and received approval for sample self-collection in May.

NEW YORK – Natera announced on Wednesday that its Prospera Lung test has received coverage from the US Centers for Medicare and Medicaid Services for single lung transplant patients in the ...

The company's CircleDNA and ACT Genomics businesses are on track to achieve business-unit breakeven in the second half of 2024, it said.

The HemoScreen instrument is a point-of-care five-part differential complete blood count analyzer that is used for rapid testing from a drop of blood.

The company, based outside of Grenoble in the French Alps, together with its partners has received €5 million to pursue the project.

Called the Coalition for Effective Diagnostics, the organization has called on lawmakers to pass legislation revamping diagnostics regulation, including oversight of LDTs.

According to the DOJ, Osman Syed submitted more than $79 million in fraudulent claims to Medicare and Texas Medicaid for RPP testing.

The company said that it is pairing its diagnostics and life sciences businesses to support growth and focus on shared end markets and customers.

The company said that gains in its Agilent CrossLab Group offset losses across its other two divisions as the company undertakes restructuring to grow as the market improves.

The company analyzes urine samples using a lateral flow test and optical reader combined with artificial intelligence to predict lung disease exacerbations.

Scientists in California and Michigan said that their FastGlioma algorithm can improve detection of tumor infiltration at the margins of surgery sites.